Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

125

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	35,121,328 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
L02AE04	GONAPEPTYL	B	Triptorelin acetate - 0.1mg	0.1mg	Injectable solution	4,637,600 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	L.L
L02BA01	TAMOXIFENE BIOGARAN	G	Tamoxifen (citrate) - 10mg	10mg	Tablet	415,247 L.L
L02BA01	TAMOXIFEN SANDOZ	G	Tamoxifen (citrate) - 20mg	20mg	Tablet, film coated	497,222 L.L
L02BA01	TAMOXIFENE BIOGARAN	G	Tamoxifen (citrate) - 20mg	20mg	Tablet	858,715 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	46,628,557 L.L
L02BA03	FULVESTRANT ARROW	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	12,644,009 L.L
L02BA03	FULVESTRANT EVER PHARMA	G	Fulvestrant - 250mg/5ml	250mg	Injectable solution	29,905,966 L.L
L02BA03	FUXRAN	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	39,382,304 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	L.L
L02BB03	CASODEX	B	Bicalutamide - 50mg	50mg	Tablet, film coated	3,777,541 L.L
L02BB03	BICALUTAMIDE ACCORD	G	Bicalutamide - 50mg	50mg	Tablet, film coated	1,382,814 L.L
L02BB03	BICALUTAMIDE BIOGARAN	G	Bicalutamide - 50mg	50mg	Tablet, coated	4,315,078 L.L
L02BB03	BICALUTAMIDE GP PHARM	G	Bicalutamide - 50mg	50mg	Tablet, film coated	1,306,215 L.L
L02BB03	BICAMIDE	G	Bicalutamide - 50mg	50mg	Tablet, film coated	1,451,753 L.L
L02BB03	PROSMIDE	G	Bicalutamide - 50mg	50mg	Tablet, film coated	3,597,914 L.L
L02BB03	CASODEX	B	Bicalutamide - 150mg	150mg	Tablet, film coated	10,863,782 L.L
L02BB04	XTANDI	B	Enzalutamide - 40mg	40mg	Capsule, soft	278,248,827 L.L
L02BB04	ENZASTIK 40	G	Enzalutamide - 40mg	40mg	Capsule	82,838,963 L.L
L02BB04	ENZASTIK 40	G	Enzalutamide - 40mg	40mg	Capsule	L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
L02BB06	NUBEQA	B	Darolutamide - 300mg		Tablet, film coated	239,808,442 L.L
L02BG03	ARIMIDEX	B	Anastrozole - 1mg	1mg	Tablet, film coated	3,202,377 L.L

...

125

...